The lifespan revolution is coming – find out what two longevity heavyweights think about the development of the antiaging industry. …
Continue reading “From biotech to inflection points with James Peyer and Greg Bailey”
Juvenescence’s Executive Chairman on demographic timebombs, the biotech mafia and ensuring founders get to participate in the upside. It’s not …
Continue reading “‘We’re at the longevity inflection point – and the explosion is coming.’”
Combined public entity to focus lead program on treatment of advanced Parkinson’s Disease. Privately held biotech Serina Therapeutics has entered …
September’s exclusive Longevity Investors Conference boasts rich agenda and A-list presenter list. More than 30 of the most prominent experts …
Continue reading “More than 30 prominent longevity speakers to attend investors-only conference”
Most recently, new Juvenescence CEO was Senior Vice-President, Global Head of Development, Respiratory & Immunology at AstraZeneca. Juvenescence has named …
Continue reading “Juvenescence appoints Dr Richard Marshall CBE as CEO”
Juvenescence Chairman explains why investing in longevity has the potential to deliver significant financial, personal and humanitarian returns. In a …
Continue reading “Jim Mellon: Longevity could be the best investment you ever make”
Synthesising nature: Juvenescence joins venture round investment in Chrysea Labs, a synthetic biology company developing nutritional interventions that maintain antiaging …
Continue reading “Juvenescence invest in Chrysea’s mystery ingredient for cellular regeneration”
Dr Brianna Stubbs discusses ketosis research and a new webinar that features leading experts in the ketone metabolism research field. …
Switch it up: Juvenescence’s ketosis-inducing drink can trigger fat-burning metabolic state. A recent study published in the Journal of American …
